Background:Approximately half of women diagnosed with advanced ovarian cancer(AOC)is over 65y.According to WHO,65y is the cut-off age for distinguishing elderly from younger people.Aim of the study was to analyze,in a 10-year retrospective series, age-related differences in perioperative outcome of cytoreductive surgery for stage IIIC-IV ovarian cancer,identifying in patients(pts) ≥65y and <65y the clinicopathological factors associated with poor prognosis. Methods:167pts with primary epithelial AOC underwent cytoreduction and platinumbased chemotherapy from 2005 to 2015 at “Sapienza”University.Pts≥65y and<65y were compared regarding surgical outcome, clinicopathological variables and prognosis.
Bmi is a key prognostic factor in stage iiic-iv ovarian cancer diagnosed prior 65 years old: a 10-year survival analysis / Ruscito, Ilary; Gasparri, Marialuisa; Marchetti, Claudia; Crispino, Stefania; La, Russa; G., C. Petriglia; DI DONATO, Violante; Palaia, Innocenza; Perniola, Giorgia; Muzii, Ludovico; BENEDETTI PANICI, Pierluigi. - In: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. - ISSN 1048-891X. - ELETTRONICO. - 25:9(2015), pp. 1480-1481. (Intervento presentato al convegno 19th International Meeting of the European Society of Gynaecological Oncology tenutosi a Nice France).
Bmi is a key prognostic factor in stage iiic-iv ovarian cancer diagnosed prior 65 years old: a 10-year survival analysis
RUSCITO, ILARY;GASPARRI, MARIALUISA;MARCHETTI, CLAUDIA;CRISPINO, STEFANIA;DI DONATO, VIOLANTE;PALAIA, INNOCENZA;PERNIOLA, GIORGIA;MUZII, LUDOVICO;BENEDETTI PANICI, PIERLUIGI
2015
Abstract
Background:Approximately half of women diagnosed with advanced ovarian cancer(AOC)is over 65y.According to WHO,65y is the cut-off age for distinguishing elderly from younger people.Aim of the study was to analyze,in a 10-year retrospective series, age-related differences in perioperative outcome of cytoreductive surgery for stage IIIC-IV ovarian cancer,identifying in patients(pts) ≥65y and <65y the clinicopathological factors associated with poor prognosis. Methods:167pts with primary epithelial AOC underwent cytoreduction and platinumbased chemotherapy from 2005 to 2015 at “Sapienza”University.Pts≥65y and<65y were compared regarding surgical outcome, clinicopathological variables and prognosis.| File | Dimensione | Formato | |
|---|---|---|---|
|
Ruscito_BMI_2015.pdf
solo utenti autorizzati
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
226.84 kB
Formato
Adobe PDF
|
226.84 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
